These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22929052)

  • 21. Endocrine disruptors and reproductive development: a weight-of-evidence overview.
    Cooper RL; Kavlock RJ
    J Endocrinol; 1997 Feb; 152(2):159-66. PubMed ID: 9071972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine disrupting chemicals: effects on human male reproductive health.
    Murray TJ; Lea RG; Abramovich DR; Haites NE; Fowler PA
    Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):80-112. PubMed ID: 11753523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health behaviors related to endocrine-disrupting chemicals and the associated factors of adolescent Korean girls.
    Park S; Chung C
    Women Health; 2018 Sep; 58(8):915-929. PubMed ID: 28805534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Environmental Endocrine-Disrupting Chemicals on Female Reproductive Health.
    Liu Q
    Adv Exp Med Biol; 2021; 1300():205-229. PubMed ID: 33523436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.
    Prusinski L; Al-Hendy A; Yang Q
    Gynecol Obstet Res; 2016 Jul; 3(1):1-6. PubMed ID: 27478869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive Impacts of Endocrine-Disrupting Chemicals on Wildlife Species: Implications for Conservation of Endangered Species.
    Tubbs CW; McDonough CE
    Annu Rev Anim Biosci; 2018 Feb; 6():287-304. PubMed ID: 29140722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?
    Dhiman SK; Dureja H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1664-1681. PubMed ID: 32504507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inadvertent issue of human retina exposure to endocrine disrupting chemicals: A safety assessment.
    Li M; Yang T; Gao L; Xu H
    Chemosphere; 2021 Feb; 264(Pt 1):128484. PubMed ID: 33022499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the Effects of Perinatal Exposure to Endocrine-Disrupting Chemicals in Animals and Humans.
    Nelson W; Wang YX; Sakwari G; Ding YB
    Rev Environ Contam Toxicol; 2020; 251():131-184. PubMed ID: 31129734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014).
    Lamb JC; Boffetta P; Foster WG; Goodman JE; Hentz KL; Rhomberg LR; Staveley J; Swaen G; Van Der Kraak G; Williams AL
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):754-7. PubMed ID: 26550933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of endocrine disruption into chemical hazard scoring for pollution prevention and current list of endocrine disrupting chemicals.
    Whaley DA; Keyes D; Khorrami B
    Drug Chem Toxicol; 2001 Nov; 24(4):359-420. PubMed ID: 11665649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure to endocrine disrupting compounds via the food chain: Is packaging a relevant source?
    Muncke J
    Sci Total Environ; 2009 Aug; 407(16):4549-59. PubMed ID: 19482336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DEDuCT 2.0: An updated knowledgebase and an exploration of the current regulations and guidelines from the perspective of endocrine disrupting chemicals.
    Karthikeyan BS; Ravichandran J; Aparna SR; Samal A
    Chemosphere; 2021 Mar; 267():128898. PubMed ID: 33190914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprint of "In silico methods in the discovery of endocrine disrupting chemicals".
    Vuorinen A; Odermatt A; Schuster D
    J Steroid Biochem Mol Biol; 2015 Sep; 153():93-101. PubMed ID: 26291836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Modifications Associated with Exposure to Endocrine Disrupting Chemicals in Patients with Gestational Diabetes Mellitus.
    Kunysz M; Mora-Janiszewska O; Darmochwał-Kolarz D
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.